chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a medical assistant refers to a 13 year old male patient. On 30-APR-2013 the patient was vaccinated with VARIVAX (Merck) (lot # h016057, expiration date 30-APR-2013), 0.5 ml, via intramuscular (anatomical location unknown). On 30-APR-2013, the patient developed numbness, tingling, redness and swelling with no induration at the injection site. The patient sought medical attention (office visit) and no treatment was given at this time. The outcome of numbness, swelling, redness and tingling was reported as not recovered/not resolved. Additional information has been assistant.
Patient presented to the ED and was subsequently hospitalized for sepsis within 6 weeks of receiving covid vaccination.
Two days later face turned red and ringing in ears. Checked blood pressure and it had skyrocketed to 202/85. This has never happened before. There was no difference in exercise or eating habits.
My immune system went into overdrive. My immune system started attacking my kidney. I was sent to the ER because they thought I was having congestive heart failure. I was admitted and had several tests done to figure out what was going on. The kidney doctor gave me a diagnosis of FSGS. I was having swelling in my feet and my legs. I was having trouble breathing and heart palpations. There was no other reason for me to have these issues but the vaccine. I have no history of kidney issues or immune issues. My kidney doctor prescribed prednisone and I was taking that for 5 months, it seemed to help but it did take 5 months and I had a lot of side effects from that. My kidney function is finally back to normal. I also had my booster vaccine and I have had no reaction to that at this point.
9FEB99 pt devel a high fever & then began to seize;pt was taken to  hosp where blood & urine testing were done on IV ATB & therapy started;pt was discharged same day. This is in follow-up to report(s) previously submitted on 5/21/99. Information has been received from a physician concerning a 16-month-old Caucasian male with stable reactive airway disease and a history of otic infection. Who on 29-JAN-1999 was vaccinated SC in the right arm with first dose of MMR II; concomitant vaccine that same day included PEDVAXHIB. On 09-FEB-1999 the patient developed high fever and then began to experience seizures and was taken to the emergency room. He was placed on IV antibiotic therapy, several laboratory testing were performed. Laboratory tests reveal the following results: CO2 = 19.0 NEQ/L; WBC = 21.5 K; LYMPH = 17.0 %. The reporter also noted that the patient was kept in the emergency room for duration of 12 hours. Upon medicail review, it was determined that febrile seizure was an important medical event. The patient recovered from all the symptoms on 09-FEB-1999. No further information is available.
Dizziness, Headache, Myalgia, Fever, NauseaVomiting, Malaise, chills Narrative:    Other Relevant History:
Within 5 minutes of the shots, my daughter walked out to the waiting room, sat next to me, told me what shots she had, said she needed some water, looked like not feeling well, I fanned her with the papers, her eyes rolled back, she stiffened, her body jerked, looked like a convulsion, it lasted less than a minute, as nurses and doctor came out to check her, her body relaxed, eyes were still closed, she said she had a dream.  Her head was very hot, her hair got wet with sweat, hands were cold and clammy.  Nurse said she fainted but I disagreed. In fainting, the body goes limp and drops. She went stiff and stayed above the chair, never fell. We gave her water, waited for about 15 minutes, nurse checked her blood pressure and let us go. When she came home she slept soundly for 1 hour. Later in the evening, she still had a low fever.  The next day her coloring is still pale.
Physician reported that the patient developed generalized urticaria and watery eyes 3 hours post vaccine. The patient recovered.
Redness, extreme swelling, over back of upper arm, itching, malaise started 24 hours after vaccination lasting four days.
not much of an apatite; hot flashes; fever of 100.5 degrees; very bad chills; body aches; cheeks were red and hot to touch; cheeks were red and hot to touch; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), FEELING HOT (cheeks were red and hot to touch), ERYTHEMA (cheeks were red and hot to touch), DECREASED APPETITE (not much of an apatite) and HOT FLUSH (hot flashes) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced PAIN (body aches), FEELING HOT (cheeks were red and hot to touch), ERYTHEMA (cheeks were red and hot to touch), PYREXIA (fever of 100.5 degrees) and CHILLS (very bad chills). On 21-Apr-2021, the patient experienced DECREASED APPETITE (not much of an apatite) and HOT FLUSH (hot flashes). On 21-Apr-2021, PAIN (body aches), FEELING HOT (cheeks were red and hot to touch), ERYTHEMA (cheeks were red and hot to touch), PYREXIA (fever of 100.5 degrees) and CHILLS (very bad chills) had resolved. At the time of the report, DECREASED APPETITE (not much of an apatite) and HOT FLUSH (hot flashes) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Apr-2021, Body temperature: 100.5 (High) fever of 100.5 degrees.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter.  Treatment details included that the patient took paracetamol for every four hours.
Patient was given the wrong 2nd covid vaccine,  1st dose was Moderna  and 2nd dose pfizer. No adverse reaction reported by patient as of now. Per health department RN educator, VAERS report to be created.
I got RSV; This spontaneous case was reported by a patient and describes the occurrence of RESPIRATORY SYNCYTIAL VIRUS INFECTION (I got RSV) in a 68-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    In October 2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In 2022, the patient experienced RESPIRATORY SYNCYTIAL VIRUS INFECTION (I got RSV). At the time of the report, RESPIRATORY SYNCYTIAL VIRUS INFECTION (I got RSV) outcome was unknown. Not Provided          Concomitant product use was not provided by the reporter. Patient received booster dose in Oct-2022 and about 10 to 14 days later patient experienced with RSV. Patient son claims that RSV caused by booster dose. However, patient did not believe that booster dose caused for RSV. Treatment information was not provided.
Pain under arm. Red strip from vax site to under arm. Arm was red and sore. Still have to this day a 2 inch wide faint strip but pain has gotten better. Pain lasted for about 3 days. Has never received this vaccine before. Checked with pharmacist on 3/19.
Swelling (a hard lump formed), redness, pain, skin warm to the touch at site of injection
Headache, fatigue, fever, large red itchy rash at injection site, arm soreness
Very large red, warm to the touch, somewhat bumpy at the site of the injection (Moderna arm)
I woke up on 3/23/21 with every reaction listed on the paperwork they gave me except a fever. I had terrible body pain as the worse reaction and it lasted 2-1/2 weeks. It seemed to be going away for 3 days then slammed me again. When my dr put me on Predisone it helped tremendously I went to the hospital about 7 days after the vaccine and they said I was having a severe reaction
Patient was given adult strength Pfizer covid vaccine at 0.2ml pediatric dose. Patient parent was informed after we got notification from Immunization Information System. Patient parent was informed no repeat or additional vaccine shot is needed.
Ache on site of injection. Shooting pain. Continues from time to time.  Pain is not just once a week and way less pain than before
This spontaneous report was received from a consumer via social media and refers to six unspecified patients of unknown age and gender. The patients' concurrent conditions and medical histories were not reported. On an unknown date, the patients were vaccinated with unspecified doses of M-M-R II (concentration, route, dose and anatomical place of vaccination were not provided), for prophylaxis. Information regarding concomitant therapies was not reported. On an unspecified date in 2016 reported as " so far in 2016",  the patients experienced mumps and the reporter stated that strength of M-M-R II vaccine was questioned (vaccination failure). At the time of reporting, the outcome of vaccination failure was unknown. The reporter did not provide a causality assessment between M-M-R II and vaccination failure.  Additional information is not expected, as no contact details were provided.
put me in bed 2 yrs in a row; Initial information received on 15-Nov-2020 regarding an unsolicited valid non-serious social media case received from the agency via a consumer.  This case involves an unknown age patient who reported put me in bed 2 years in a row (Bedridden), while she received INFLUENZA VACCINE.  The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number and expiration date not reported via unknown route at unknown administration site for prophylactic vaccination.  On an unknown date, the patient who reported put me in bed 2 years in a row (Bedridden), unknown latency following the administration of INFLUENZA VACCINE.  No relevant laboratory test was reported.  Final diagnosis was Bedridden.  It was not reported if the patient received a corrective treatment.  The outcome was unknown, at the time of reporting.  There will be no information available on the batch number for this case.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 49-year-old male patient received BNT162b2 (BNT162B2), on 18Mar2021 at 13:00 as dose 1, single (Lot number: EN6208), in left arm, on 06Apr2021 at 13:00 as dose 2, single (Lot number: EW0151), in left arm and on 30Nov2021 at 13:00 as dose 3 (booster), single (Lot number: FF2589) at the age of 48 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical information: Patient had no known allergies. No follow-up attempts are possible. No further information is expected.
I received my first Pfizer vaccine over a year ago.  4 hours after I received my first vaccine I developed numbness and tingling in the arm I received my injection.  I am a nurse and it looked exactly like Raynaud's phenomena.  It was only in the arm I received my injection and it my right hand and fingers would turn numb an turn white randomly for the next three weeks.
pt recvd MMR vax 9APR91 & on 12APR91 pt c/o chills, malaise, mild diarrhea, joint pain, nausea; pts t96.0; pt presented to ER t96, BP 120/80, P86 & regular; lab eval revealed CBC WNL; MD felt pt's condition was related to the vax;
This spontaneous report as received from a patient's mother refers to an approximately 26 year old non-pregnant female patient. There were no concomitant medications, concurrent conditions and medical history reported. In February 2008, September 2008 and January 2009, the patient was vaccinated with first, second and third dose respectively of GARDASIL (route and site of administration, lot number, expiration date and indication were not reported). It was reported that the patient was hospitalized at the beginning of 2009 (reported as 20 days after receiving the third and final dose of GARDASIL). At the time of hospitalization, the doctors stated that the patient's "immune system was attacking her". It was also reported that the right side of the patient's body "had essentially been crippled". She no longer had the ability to move her right hand backwards and muscle growth along the right side of her body had ceased. There was no flexibility in the patient's right foot. In order to walk the patient had to "drag her leg" and driving was very difficult for her. The reporter also stated that the patient's symptoms have gotten worse since the original symptoms have developed. The patient's mother also reported that the patient's right ankle bone was much bigger than her left ankle, during the call she compared the right ankle to "that of 60 year old woman", she also mentioned that the patient experienced unspecified symptoms related to her condition occurring in her ribcage area. Lab diagnostic studies included bone tests on wrists and ankles, x-rays, and computerised tomography (CT) (results not provided). The patient sought medical attention via several doctors visits. The outcome of the events was reported as not recovered/not resolved at the time of the report. The reporter did not provide the relatedness, however the doctors at the hospital did not associate the patient's symptoms with the GARDASIL. The reporter considered the events as significant disability. Upon internal review the event of hemiplegia was considered as medically significant. Additional information has been requested.
My daughter has been vomiting nearly everything she takes in. Thick, foamy vomit. Began 2 hrs after vaccines, and still going this morning.
I received a vaccination from pharmacy technician which I believe the site of administration was too high (close/near the shoulder joint. This has resulted in severe joint pain that limits mobility, which has persisted for greater than a week after receiving vaccination. I have taken OTC Tylenol and Motrin, which have given short term pain relief, but the severe still persists.
Received 2/22/08 DTaP+IPV (L) thigh + Hep A + Hep B - (R) thigh. (L) thigh increased in size 2/22/08 per mother and had been limping. Seen in ER 3/2/08 - sent home. Seen PCP 3/6/08 - admitted to hospital. Unable to walk for almost 6-7 days prior to admission. Consecutive u/s + MRI's done. Showed extensive pyomyositis and focal abscesses within lateral aspect of vastus intermedius muscle. There was concern of necrotizing fascitis. Hospitalized 10 days total. Transferred to tertiary hospital. Treated with IV antibiotics 8-9 days total and PO abx for another 7-8 days.  10/10/08-records received-Presented to ED on 3/2/08-with 2 day history of swelling and pain in left anterior thigh and tactile fever. Received 2 shots 2 days prior. Currently receiving treatment for infection on side of face. DX:local reaction to immunization, cellulitis, hematoma, injury. 12/18/08-records received for DOS 3/9-3/15/08-DC DX:Left leg abscess/myositis. Microcytic anemia. Presented with swelling of left thigh on 3/6/08, painful.Febrile.
No adverse effects reported.; the patient was administered an expired dose of VARIVAX; Information has been received from a registered nurse, referring to a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant medications were not provided.     On 06-NOV-2019, the patient was vaccinated with one expired dose of varicella virus vaccine live (oka/merck) (VARIVAX) (lot # N027618, expiration date 04-OCT-2019, strength was unknown) intramuscularly, as prophylaxis (also reported as routine vaccination). Upon this report, no adverse effects were reported.
Excessive fatigue lasting 2.5 days. Would get up to walk to the restroom and could only take steps that were about 6 inch strides and a walk that should only take 4-5 seconds would take 45 seconds each way. Inability to write legibly with a pen or open a bottle of Tylenol because of the protective seal. Convulsions while trying to breathe.
Patient has been having sore arm, body aches, and headache for 9 days following covid injection.
On the day of the injection: severe arm pain from the minute the needle enter my arm and lasted 3-4 days; immediate swelling that lasted 5 days; severe fatigue, severe diarrhea within 4 hours after the shot; headache; I slept for 3 days but the fatigue has never left;  later on, I became dizzy, headaches continue to this day;  fatigue is debilitating.  One episode, I nearly fell on the floor.  Most episodes now last about 3-5 seconds.  However, beginning 24 Apr, I woke with dizziness and so far it has lasted 2 days now. I'm scheduled to see my PCP today (26 Apr) to discuss - I did not put 2+2 together until I started looking at my notes seeing that these symptoms co-insided with my Moderna injection.  I thought something other might be happening. I reviewed the side effects on line this AM and realized my issues are most likely related to the injection.
ended up hospitalized due to stroke symptoms; She has been having side effects still to this day including weakness, headaches, and lethargy; She has been having side effects still to this day including weakness, headaches, and lethargy; She has been having side effects still to this day including weakness, headaches, and lethargy; This is a spontaneous report received from a contactable reporter(s) (Other HCP).  An elderly female patient (not pregnant) received BNT162b2 (BNT162B2), in 2022 as DOSE 4 (booster), SINGLE (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1), for COVID-19 immunization; Bnt162b2 (DOSE 2), for COVID-19 immunization; Bnt162b2 (DOSE 3), for COVID-19 immunization.  The following information was reported: CEREBROVASCULAR ACCIDENT (hospitalization, medically significant), outcome "recovering", described as "ended up hospitalized due to stroke symptoms"; ASTHENIA (hospitalization), HEADACHE (hospitalization), LETHARGY (hospitalization), outcome "recovering" and all described as "She has been having side effects still to this day including weakness, headaches, and lethargy". The events "ended up hospitalized due to stroke symptoms" and "she has been having side effects still to this day including weakness, headaches, and lethargy" required physician office visit. It was unknown if therapeutic measures were taken as a result of cerebrovascular accident, asthenia, headache, lethargy. Clinical course: Reporter was told by friend that her mother had been having extended side effects after her second booster. Reporter ascertained that all 4 vaccinations have been Pfizer. She said that she got the vaccine at the end of May2022 or beginning of Jun2022 and ended up hospitalized due to stroke symptoms. She had been having side effects still to this day including weakness, headaches, and lethargy. This was the extent of information.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of the reported event cerebrovascular accident, asthenia, headache, lethargy Cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
606 doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided.  No adverse events reported.   No temperature excursion of the product was reported.  There was no product complaint associated. Vaccine was refrigerated on 18-Nov-2021.  No treatment information was provided.   This case was linked to MOD-2022-491837 (Patient Link).
Received vaccines on 1/3/2020 afternoon. Woke up on 1/4/2020 with left leg swollen around injection site. Warm to touch. Mom placed ice pack. Swelling did come down that day. Seen on 1/6/2020 by physician. No infection was seen.
Employee administered vaccine at 0725.  At about 0740 he began to feel lightheaded, dizzy, and nauseous.  He also became pale and diaphoretic.  Gave some water and monitored for several more minutes.  He stood up at 0747 as he stated that he was feeling much better.  When he stood up, he became dizzy and lightheaded again.  Had him sit down, cool down, had a few sips of water.  BP 148/95, HR 83, O2 sat was 99%.  He did state that the vaccine burned for about 2-3 minutes when administered.  Had him sit for 10 more minutes and he stated that he was feeling much better.  He stood up and was feeling much better.  He was offered to go to the emergency room and refused.  He was escorted to his department by an RN observer.  At this time, he has no symptoms and states he is feeling good.
patient reported aching joints after the shot (generalized joint aches) persisting weeks later. He recently informed me that he went to the MD & was diagnosed with PMR (polymyalgia rheumatica) & was prescribed with steroid which helped him per patient.
severe h/a requiring injectable narcotics; 11MAR93 severe cephalgia 1-2 hrs post inject; seen in ER & given injectable analagesia; pt is completing series & had cephalgia p/each dose since dose 3;
Localized swelling and redness, about 4-5 cm in diameter over the injection site. Swelling in the ipsilateral axilla, about 6-7 cm in diameter and mildly tender. The reaction appeared 4 days after receiving the Prevnar and improved on its own after 4 days. Required no treatment for the adverse event.